A Phase 4 interventional study of valproic acid and placebo bid in Post Cerebral Hemorrhage, sponsored by Wolfson Medical Center. Completed. Per ClinicalTrials.gov, last updated 2014-06-12.
Sponsored by Wolfson Medical Center · Phase 4, Interventional, and Prevention
This study examines early antiepileptic treatment with valproic acid for acute cerebral hemorrhage against a placebo group immediately post event to evaluate the outcome of these patients regarding seizures and neurological outcome.
476 studies on the registry are indexed under Cerebral Hemorrhage; 181 are open to participants now.
This study's enrollment of 72 is below the median of 100 across 287 interventional studies indexed under Cerebral Hemorrhage.
Browse Cerebral Hemorrhage studies →Wolfson Medical Center is the lead sponsor of 113 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Valproic acid given orally 400mg twice daily
Drug: valproic acid · Drug: placebo bid
Placebo twice daily for one month
Drug: placebo bid
treatment of 1 month dosage of 400 mg BID
number of seizures
Time frame: study drug for 1 month and 1 year follow up
neurological outcome NIHSS
Time frame: during 1 month study drug and 1 year post follow up
No study locations are listed for this record.
This study is completed, as verified in May 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Wolfson Medical Center